vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Forestar Group Inc. (FOR). Click either name above to swap in a different company.
Forestar Group Inc. is the larger business by last-quarter revenue ($273.0M vs $168.4M, roughly 1.6× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 9.0%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -9.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Forestar Group Inc. is a residential lot development company based in Arlington, Texas. The company has operations in 51 markets in 21 states and delivered 11,518 residential lots during the twelve-month period ended December 31, 2020. The company is publicly traded on the New York Stock Exchange and in October 2017 became a majority-owned subsidiary of D.R. Horton, Inc., the largest homebuilder by volume in the United States since 2002. The company primarily acquires entitled real estate and...
ESPR vs FOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $273.0M |
| Net Profit | — | $15.4M |
| Gross Margin | — | 20.1% |
| Operating Margin | 50.6% | 7.6% |
| Net Margin | — | 5.6% |
| Revenue YoY | 143.7% | 9.0% |
| Net Profit YoY | — | -6.7% |
| EPS (diluted) | $0.32 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $273.0M | ||
| Q3 25 | $87.3M | $670.5M | ||
| Q2 25 | $82.4M | $390.5M | ||
| Q1 25 | $65.0M | $351.0M | ||
| Q4 24 | $69.1M | $250.4M | ||
| Q3 24 | $51.6M | $551.3M | ||
| Q2 24 | $73.8M | $318.4M | ||
| Q1 24 | $137.7M | $333.8M |
| Q4 25 | — | $15.4M | ||
| Q3 25 | $-31.3M | $86.9M | ||
| Q2 25 | $-12.7M | $32.9M | ||
| Q1 25 | $-40.5M | $31.6M | ||
| Q4 24 | — | $16.5M | ||
| Q3 24 | $-29.5M | $81.5M | ||
| Q2 24 | $-61.9M | $38.7M | ||
| Q1 24 | $61.0M | $45.0M |
| Q4 25 | — | 20.1% | ||
| Q3 25 | — | 22.3% | ||
| Q2 25 | — | 20.4% | ||
| Q1 25 | — | 22.6% | ||
| Q4 24 | — | 22.0% | ||
| Q3 24 | — | 23.9% | ||
| Q2 24 | — | 22.5% | ||
| Q1 24 | — | 24.9% |
| Q4 25 | 50.6% | 7.6% | ||
| Q3 25 | -11.4% | 16.9% | ||
| Q2 25 | 8.6% | 11.2% | ||
| Q1 25 | -34.0% | 11.6% | ||
| Q4 24 | -6.4% | 8.7% | ||
| Q3 24 | -31.0% | 19.7% | ||
| Q2 24 | 3.5% | 16.2% | ||
| Q1 24 | 52.5% | 17.6% |
| Q4 25 | — | 5.6% | ||
| Q3 25 | -35.9% | 13.0% | ||
| Q2 25 | -15.4% | 8.4% | ||
| Q1 25 | -62.2% | 9.0% | ||
| Q4 24 | — | 6.6% | ||
| Q3 24 | -57.2% | 14.8% | ||
| Q2 24 | -83.9% | 12.2% | ||
| Q1 24 | 44.3% | 13.5% |
| Q4 25 | $0.32 | $0.30 | ||
| Q3 25 | $-0.16 | $1.70 | ||
| Q2 25 | $-0.06 | $0.65 | ||
| Q1 25 | $-0.21 | $0.62 | ||
| Q4 24 | $-0.14 | $0.32 | ||
| Q3 24 | $-0.15 | $1.59 | ||
| Q2 24 | $-0.33 | $0.76 | ||
| Q1 24 | $0.34 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $211.7M |
| Total DebtLower is stronger | — | $793.2M |
| Stockholders' EquityBook value | $-302.0M | $1.8B |
| Total Assets | $465.9M | $3.2B |
| Debt / EquityLower = less leverage | — | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $211.7M | ||
| Q3 25 | $92.4M | $379.2M | ||
| Q2 25 | $86.1M | $189.2M | ||
| Q1 25 | $114.6M | $174.3M | ||
| Q4 24 | $144.8M | $132.0M | ||
| Q3 24 | $144.7M | $481.2M | ||
| Q2 24 | $189.3M | $359.2M | ||
| Q1 24 | $226.6M | $416.2M |
| Q4 25 | — | $793.2M | ||
| Q3 25 | — | $802.7M | ||
| Q2 25 | — | $872.8M | ||
| Q1 25 | — | $872.5M | ||
| Q4 24 | — | $806.8M | ||
| Q3 24 | — | $706.4M | ||
| Q2 24 | — | $706.1M | ||
| Q1 24 | — | $705.7M |
| Q4 25 | $-302.0M | $1.8B | ||
| Q3 25 | $-451.4M | $1.8B | ||
| Q2 25 | $-433.5M | $1.7B | ||
| Q1 25 | $-426.2M | $1.6B | ||
| Q4 24 | $-388.7M | $1.6B | ||
| Q3 24 | $-370.2M | $1.6B | ||
| Q2 24 | $-344.2M | $1.5B | ||
| Q1 24 | $-294.3M | $1.5B |
| Q4 25 | $465.9M | $3.2B | ||
| Q3 25 | $364.0M | $3.1B | ||
| Q2 25 | $347.1M | $3.1B | ||
| Q1 25 | $324.0M | $3.0B | ||
| Q4 24 | $343.8M | $3.0B | ||
| Q3 24 | $314.1M | $2.8B | ||
| Q2 24 | $352.3M | $2.7B | ||
| Q1 24 | $373.1M | $2.6B |
| Q4 25 | — | 0.44× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.47× | ||
| Q1 24 | — | 0.48× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $-157.0M |
| Free Cash FlowOCF − Capex | — | $-157.1M |
| FCF MarginFCF / Revenue | — | -57.5% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | -10.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $93.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $-157.0M | ||
| Q3 25 | $-4.3M | $256.3M | ||
| Q2 25 | $-31.4M | $15.8M | ||
| Q1 25 | $-22.6M | $-19.8M | ||
| Q4 24 | $-35.0M | $-450.0M | ||
| Q3 24 | $-35.3M | $119.2M | ||
| Q2 24 | $-7.2M | $-61.7M | ||
| Q1 24 | $53.8M | $-59.2M |
| Q4 25 | — | $-157.1M | ||
| Q3 25 | — | $255.6M | ||
| Q2 25 | — | $15.0M | ||
| Q1 25 | — | $-20.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-35.5M | $118.4M | ||
| Q2 24 | $-7.3M | $-62.3M | ||
| Q1 24 | $53.8M | $-59.8M |
| Q4 25 | — | -57.5% | ||
| Q3 25 | — | 38.1% | ||
| Q2 25 | — | 3.8% | ||
| Q1 25 | — | -5.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.7% | 21.5% | ||
| Q2 24 | -9.9% | -19.6% | ||
| Q1 24 | 39.0% | -17.9% |
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.3% | 0.1% | ||
| Q2 24 | 0.1% | 0.2% | ||
| Q1 24 | 0.1% | 0.2% |
| Q4 25 | — | -10.19× | ||
| Q3 25 | — | 2.95× | ||
| Q2 25 | — | 0.48× | ||
| Q1 25 | — | -0.63× | ||
| Q4 24 | — | -27.27× | ||
| Q3 24 | — | 1.46× | ||
| Q2 24 | — | -1.59× | ||
| Q1 24 | 0.88× | -1.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
